99% Savings - Buy Just @1 Rs X
Olmefit is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of High BP. Other than this, Olmefit has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Olmefit depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Common side effects of Olmefit include Upper respiratory tract infection. Apart from the aforementioned side effects, Olmefit can also lead to other problems, which have been listed below. Usually, these side effects of Olmefit go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olmefit is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Olmefit related warnings talks about Olmefit's effects on the liver, heart and kidney.
Olmefit is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) are examples of such conditions. The section on Olmefit contraindications lists all such conditions.
Drug interactions for Olmefit have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Olmefit is not safe while driving, and is not addiction.
Olmefit is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Olmefit safe for pregnant women?
Olmefit has many dangerous side effects in pregnant women. If you are pregnant, do not consume Olmefit without medical advice.
Is the use of Olmefit safe during breastfeeding?
Olmefit has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmefit on the Kidneys?
Very few cases of side effects of Olmefit on kidney have been reported.
What is the effect of Olmefit on the Liver?
Olmefit has very mild side effects on the liver.
What is the effect of Olmefit on the Heart?
Side effects of Olmefit rarely affect the heart.
Olmefit should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmefit unless your doctor advises you to do so -
Is this Olmefit habit forming or addictive?
Olmefit does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olmefit you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Olmefit is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Olmefit in mental disorders is not effective.
Interaction between Food and Olmefit
Eating certain foods may increase the time it takes Olmefit to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Olmefit
Consult your doctor before consuming alcohol while taking Olmefit as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173